Singapore, April 29 -- Arcera Life Sciences, a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group, an innovation-driven global pharmaceutical and healthcare group, have announced the signing of a Memorandum of Understanding (MoU) to establish a long-term strategic collaboration focused on licensing, technology development, neuroscience innovation and value creation in the global life sciences sector.

The collaboration combines Fosun Pharma's world-class R&D and manufacturing capabilities with Arcera's international market access and commercial infrastructure, positioning Abu Dhabi as a premier bridge between Chinese biotech innovation and global markets while accelerating patient access to br...